Terms: = Sarcomas AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566
45 results:
1. Using tumor habitat-derived radiomic analysis during pretreatment
Zhao H; Su Y; Wang Y; Lyu Z; Xu P; Gu W; Tian L; Fu P
Cancer Imaging; 2024 Feb; 24(1):26. PubMed ID: 38342905
[TBL] [Abstract] [Full Text] [Related]
2. A Modification of the American Joint Committee on Cancer Nomogram for Undifferentiated Sarcoma With External Validation and Risk Stratification.
Yuan J; Zhang X; Zhang S; Yu S
Am Surg; 2024 Apr; 90(4):762-769. PubMed ID: 37905507
[TBL] [Abstract] [Full Text] [Related]
3. Clinical model of pulmonary metastasis in patients with osteosarcoma: A new multiple machine learning-based risk prediction.
Su Z; Huang F; Yin C; Yu Y; Yu C
J Orthop Surg (Hong Kong); 2023; 31(2):10225536231177102. PubMed ID: 37288764
[TBL] [Abstract] [Full Text] [Related]
4. MRI Fat-Saturated T2-Weighted Radiomics Model for Identifying the Ki-67 Index of Soft Tissue sarcomas.
Yang Y; Zhang L; Wang T; Jiang Z; Li Q; Wu Y; Cai Z; Chen X
J Magn Reson Imaging; 2023 Aug; 58(2):534-545. PubMed ID: 36326136
[TBL] [Abstract] [Full Text] [Related]
5. Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1325-1332. PubMed ID: 35953276
[TBL] [Abstract] [Full Text] [Related]
6. Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma.
Diggs A; Sia TY; Huang Y; Gockley A; Melamed A; Khoury-Collado F; St Clair C; Hou JY; Hershman DL; Wright JD
Gynecol Oncol; 2022 Aug; 166(2):308-316. PubMed ID: 35660331
[TBL] [Abstract] [Full Text] [Related]
7. MRI for evaluation of preoperative chemotherapy in osteosarcoma.
Yildirim O; Al Khatalin M; Kargin OA; Camurdan VB
Radiography (Lond); 2022 Aug; 28(3):593-604. PubMed ID: 35537246
[TBL] [Abstract] [Full Text] [Related]
8. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
[TBL] [Abstract] [Full Text] [Related]
9. [Differential diagnosis between pulmonary artery sarcoma and central chronic pulmonary thromboembolism:a preliminary study on CT signs].
Wang HP; Song W; Liu S; Gao Y; An YQ; Hou ZH; Xiong CM; Hua L; Sun Y; Lyu B
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Mar; 45(3):269-275. PubMed ID: 35279990
[No Abstract] [Full Text] [Related]
10. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract] [Full Text] [Related]
11. Cancer predisposition genes in Japanese children with rhabdomyosarcoma.
Fukushima H; Suzuki R; Yamaki Y; Hosaka S; Inaba M; Morii W; Noguchi E; Takada H
J Hum Genet; 2022 Jan; 67(1):35-41. PubMed ID: 34257391
[TBL] [Abstract] [Full Text] [Related]
12. Expression and prognosis analyses of BUB1, bub1b and BUB3 in human sarcoma.
Long Z; Wu T; Tian Q; Carlson LA; Wang W; Wu G
Aging (Albany NY); 2021 Apr; 13(9):12395-12409. PubMed ID: 33872216
[TBL] [Abstract] [Full Text] [Related]
13. Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sites.
Snow A; Ring A; Struycken L; Mack W; Koç M; Lang JE
Cancer Epidemiol; 2021 Feb; 70():101857. PubMed ID: 33249363
[TBL] [Abstract] [Full Text] [Related]
14. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
15. [Application of apparent diffusion coefficient combined with serum tumor markers detection in evaluating neoadjuvant chemotherapy for osteosarcoma].
Wang Z; Liu L; Song YX; Zhang H; She W; Qian YW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1012-1016. PubMed ID: 32294859
[No Abstract] [Full Text] [Related]
16. Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.
Younger E; Ballman K; Lu Y; Pápai Z; Van Tine BA; Attia S; Schöffski P; Reinke D; Tap WD; Jones RL
J Geriatr Oncol; 2020 Apr; 11(3):463-469. PubMed ID: 31126845
[TBL] [Abstract] [Full Text] [Related]
17. Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.
Yu D; Zhang S; Feng A; Xu D; Zhu Q; Mao Y; Zhao Y; Lv Y; Han C; Liu R; Tian Y
Medicine (Baltimore); 2019 May; 98(19):e15582. PubMed ID: 31083238
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.
Zheng C; You W; Wan P; Jiang X; Chen J; Zheng Y; Li W; Tan J; Zhang S
Medicine (Baltimore); 2018 Jun; 97(25):e11004. PubMed ID: 29923984
[TBL] [Abstract] [Full Text] [Related]
19. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma.
Roberto GM; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Pathol Res Pract; 2018 Feb; 214(2):213-216. PubMed ID: 29254787
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
[TBL] [Abstract] [Full Text] [Related]
[Next]